RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp Grants Option to Consumer Health Division of Sanofi, page-9

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 1,605 Posts.
    lightbulb Created with Sketch. 202

    Close... It's the exclusive option to have a commercial agreement.
    Kind of like an MOU as I read it, but seems more solid.
    It also indicates that after this week of Creasphere Sanofi likes what they saw and now Resapp will have help adding to the products their involved in. A great validation of the technology again. Pleased to get an update like this after so much quiet, even if it's not the other ones we're waiting for it shows that the participation in Creasphere is already more than just a PR piece.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.